found that OCT3/4 increased tumor immune escape via upregulation of TET1 and NRF2 expression, leading to enhancement of MDM2 expression, which contributed to acceleration of tumor immune evasion in bladder cancer (70). Here, MDM2 is linked to urinary bladder cancer.